Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Lincoln Pharmaceuticals Ltd

NSE: LINCOLN · BSE: 531633 · Pharmaceuticals & Biotechnology · 5 announcements

Share price
₹591.00
Market cap
₹1,184 Cr
Revenue (annual)
₹671.0 Cr
Net profit (annual)
₹87.89 Cr
P/E (TTM)
12.3×Sector 50.4×
Promoter holding
49.78%+0.00% QoQ
FII holding
4.60%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:49 IST BSE
Annual Report

Lincoln Pharmaceuticals Annual Report

Lincoln Pharmaceuticals submitted its Annual Report for FY 2025-26 and notice for the 32nd Annual General Meeting scheduled for September 30, 2026.